The development of interventional cardiology

Journal of the American College of Cardiology

Volumn 31, Issue 4 SUPPL. B, 1998, Pages 64B-88B

  King III, Spencer B ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ANGIOPLASTY; CORONARY ARTERY DILATATION; HISTORY OF MEDICINE; MEDICAL EDUCATION; MEDICAL SPECIALIST; PRIORITY JOURNAL; REVIEW;

EID: 0032520929     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00558-5     Document Type: Review

References (356)

1. Hurst JW. History of cardiac catheterization. In: King SB III, Douglas JS Jr, editors. Coronary Arteriography and Angioplasty. New York: McGraw-Hill, 1985:1-9.
2. Forssmann W. The catheterization of the right side of the heart. Klin Wochenschr 1929;8:2085.
3. Forssmann W. Experiments on Myself: Memoirs of a Surgeon in Germany. New York: St. Martin's Press, 1974:84-5.
4. Klein O. Determining human cardiac output (minute volume) using Fick's principle (extraction of mixed venous blood by cardiac catheterization). Med Wochenschr 1930;77:1311.
5. Cournand A, Ranges HA. Catheterization of the right auricle in man. Proc Soc Exp Biol Med 1941;46:462.
6. Cournand A, Riley RL, Bradley SE, et al. Studies of the circulation in clinical shock. Surgery 1943;13:964.
7. Brannon ES, Weens HS, Warren JW. Atrial septal defect: Study of hemodynamics by the technique of right heart catheterization. Am J Med Sci 1945;210:480.
8. Stead EA, Warren JV, Merrill AJ, Brannon ES. The cardiac output in male subjects as measured by the technique of right atrial catheterization: Normal values with observations on the effect of anxiety and tilting. J Clin Invest 1945;24:326.
9. Warren JV, Stead EA. Fluid dynamics in chronic congestive heart failure: An interpretation of the mechanisms producing the edema, increased plasma volume and elevated venous pressure in certain patients with prolonged congestive failure. Arch Intern Med 1944;73:138.
10. Zimmerman HA, Scott RW, Becker NO. Catheterization of the left side of the heart in man. Circulation 1950;1:357.
11. Baltaxe HA, Amplatz K, Levin DC. Coronary Angiography. Springfield, Charles C Thomas, 1976.
12. Moniz E, DeCarvalho L, Lima A. Angiopneumographie. Presse Med 1931;39:996.
13. Reboul H, Racine M. La ventriculographie cardiaque experimentale. Presse Med 1933;1:763.
14. Radner S. An attempt at the roentgenologic visualization of the coronary blood vessels in man. Acta Radiol 1945;26:497.
15. DiGuglielmo L, Guttaduro M. Roentgenologic study of coronary arteries in living. Acta Radiol Suppl (Stockh) 1952;97.
16. Dotter CT, Frische LH. Visualization of the coronary circulation by occlusion aortography: a practical method. Radiology 1958;76:502.
17. Arnulf G, Chacornac R. Communication to La Societe de Chirurgie de Lyon, November 14, 1957, in Arnulf G: L'arteriographie methodique des arteres coronaires grace a l'utilisation de l'acetylcholine: Donnees experimentales et cliniques. Bull Acad Natl Med (Paris) 1958;25/26:661.
18. Richard LS, Thal AP. Phasic dye injection control system for coronary arteriography in the human. Surg Gynecol Obstet 1958;107:739.
19. Bellman S, Frank HA, Lambert PB, Littman D, Williams JA. Coronary arteriography: I. Differential opacification of the aortic stream catheters of special design: Experimental development. N Engl J Med 1960;262:325.
20. Nordenstrom B. Contrast examination of the cardiovascular system during increased intrabronchial pressure. Acta Radiol Suppl (Stockh) 1960;200 Suppl:110.
21. Bilgutay AM, Gannon P, Sterns LP, Ferlic R, Lillehei CW. Coronary arteriography: New method under induced hypotension by pacing-experimental and clinical application. Arch Surg 1964;89:899.
22. Sones FM Jr. Coronary arteriography. Read before the Eighth Annual Convention of the American College of Cardiology, Philadelphia, 1959.
23. Favaloro RG. Critical analysis of coronary artery bypass grafting: a 30-year journey. J Am Coll Cardiol 1998;31:1B-63B.
24. Garrett HE, Dennis EW, DeBakey ME. Aorto coronary bypass with saphenous vein graft. JAMA 1973;223:792-4.
25. Johnson WD, Flemma RJ, Lepley D Jr, et al. Extended treatment of severe coronary artery disease: a total surgical approach. Ann Surg 1969;170:460-70.
26. Green GE, Stertzer SH, Reppert EH. Coronary arterial bypass grafts. Ann Thorac Surg 1968;5:443-50.
27. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: Description of a new technique and preliminary report of its application. Circulation 1964;30:654.
28. Dotter CT, Rosch J, Judkins MP. Transluminal dilatation of arteriosclerotic stenosis. Surg Gynecol Obstet 1968;127:794.
29. Porstmann W. Ein neuer Korsett-Ballonkatheter zur transluminalen Rekanalisation nach Dotter unter besonderer Berucksichtigung von Obliterationen an den Beckenarterien. Radiol Diagn 1973;14:239-43.
30. Wierny L, Plass R, Porstmann W. Long-term results in 100 consecutive patients treated by transluminal angioplasty. Radiology 1974;112:543.
31. Zeitler E, Schoop W, Zahnow W. The treatment of occlusive arterial disease by transluminal catheter angioplasty. Radiology 1971;99:19-26.
32. King SB III. Angioplasty from bench to bedside to bench. Circulation 1996;93:1621-9.
33. Gruentzig A, Turina M, Schneider J. Experimental percutaneous dilatation of coronary artery stenosis [abstract]. Circulation 1976;54 Suppl:81.
34. Gruentzig AR, King SB, Schlumpf M, Siegenthaler W. Long term followup after percutaneous transluminal coronary angioplasty: the early Zurich experience. N Engl J Med 1987;316:1127-32.
35. King SB III, Schlumpf M. Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol 1993;22:353-60.
36. Meier B, Gruentzig AR, King SB III, et al. Risk of side branch occlusion during coronary angioplasty. Am J Cardiol 1984;53:10-4.
37. King SB III, Douglas JS, Gruentzig AR. Percutaneous transluminal coronary angioplasty. In: King SB III, Douglas JS, editors. Coronary Angiography and Angioplasty. New York: McGraw-Hill, 1985:433-60.
38. Carr MK. The use of the guiding catheter in coronary angioplasty: the technique of manipulating catheters to obtain the necessary power to cross tight coronary stenoses. Cathet Cardiovasc Diagn 1986;12:189-97.
39. Newton CM, Lewis SA, Vetrovec GW. Technique for guiding catheter exchange during coronary angioplasty while maintaining guidewire access across a coronary stenosis. Cathet Cardiovasc Diagn 1986;15:173-5.
40. Kulick DL. Use of the internal mammary artery guiding catheter for percutaneous transluminal coronary angioplasty of the shepherd's crook right coronary artery. Cathet Cardiovasc Diagn 1989;16:190-2.
41. Arani DT, Bunnell IL, Visco JP, Conley JG. Double loop guiding catheter: A primary catheter for angioplasty of the right coronary artery. Cathet Cardiovasc Diagn 1988;15:125-31.
42. Douglas JS Jr, King SB III. Pathoanatomy of the coronary arteries. In: King SB III, Douglas JS, editors. Coronary Arteriography and Angioplasty. New York: McGraw-Hill, 1985:86-121.
43. Meier B, Gruentzig AR, Dekmezian RH, Brown JE. Percutaneous perfusion of occluded coronary arteries with blood from the femoral artery: A dog study. Cathet Cardiovasc Diagn 1985;11:81-7.
44. Hopf R, Kunkel B, Schneider M, Kaltenbach M. Koronarperfusion bei akutem Gefassverschluss im Rahmen der transluminalen Koronarangioplastick (TCA). Z Kardiol 1985;74:580-4.
45. Angelini P, Heibig J, Leachman DR. Distal hemoperfusion during percutaneous transluminal coronary angioplasty. Am J Cardiol 1986;58:252-5.
46. Hinohara T, Simpson JB, Phillips HR, et al. Transluminal catheter reperfusion: a new technique to reestablish blood flow after coronary occlusion during percutaneous transluminal coronary angioplasty. Am J Cardiol 1986;57:684-6.
47. Busch U, Erbel R, Clas W, et al. Verbesserete Okklusionstoleranzzeit durch kontinuierliche Koronarperfusion mit modifiziertem. Gruentzig-Koronarangioplastiekatheter. Z Kardiol 1985;74:435-9.
48. Erbel R, Rupprecht HJ, Busch U, et al. Continuous coronary perfusion and prolonged balloon inflation during stenosis dilatation. Z Kardiol 1987;76: 49-52.
49. Stack RS, Quigley PJ, Collins G, Phillips HR III. Perfusion balloon catheter. Am J Cardiol 1988;61:77G-80G.
50. Quigley PJ, Hinohara T, Phillips HR, et al. Myocardial protection during coronary angioplasty with an autoperfusion balloon catheter in humans. Circulation 1988;78:1128-34.
51. Sundram P, Harvey JR, Johnson RG, Schwartz MJ, Baim DS. Benefits of the perfusion catheter for emergency coronary artery grafting after failed percutaneous transluminal coronary angioplasty. Am J Cardiol 1989;63: 282-5.
52. Talley J, Weintraub W, Anderson H, et al. Late clinical outcome of coronary bypass surgery after failed elective PTCA [abstract]. Circulation 1987;76 Suppl IV:IV-352.
53. Page US, Okies JE, Colburn LQ, Bigelow JC, Salomon NW, Krause AH. Percutaneous transluminal coronary angioplasty: a growing surgical problem. J Thorac Cardiovasc Surg 1986;92:847-852.
54. Murphy DA, Craver JM. Emergency bypass surgery of patients undergoing percutaneous coronary angioplasty. In: Jang GD, editor. Angioplasty. New York: McGraw-Hill, 1985:357-367.
55. Van Tassel, RA, Gobel FL, Rydell MA, Vlodaver Z, MacCarter DJ. A less traumatic catheter for coronary arteriography. Cathet Cardiovasc Diagn 1985;11:187-99.
56. Meier B. Kissing balloon coronary angioplasty. Am J Cardiol 1984;54:918-920.
57. Zack PM, Ischinger T. Experience with a technique for coronary angioplasty of bifurcational lesions. Cathet Cardiovasc Diagn 1984;10:433-43.
58. Pinkerton CA, Slack JD, van Tassel JW, Orr CM. Angioplasty for dilatation of complex coronary artery bifurcation stenoses. Am J Cardiol 1985;55: 1626-8.
59. Oesterle SN, McAuley BJ, Buchbinder M, Simpson JB. Angioplasty at coronary bifurcations: single-guide, two-wire technique. Cathet Cardiovasc Diagn 1986;12:57-62.
60. George BS, Myler RK, Stertzer SH, et al. Balloon angioplasty of coronary bifurcation lesions: the kissing balloon technique. Cathet Cardiovasc Diagn 1986;12:124-38.
61. Hartzler GO. Three-wire technique: a unique approach to percutaneous transluminal coronary angioplasty of a trifurcation lesion. Cathet Cardiovasc Diagn 1987;13:174-7.
62. Nath A, Vetrovec GW, Cowley MJ, et al. Double-wire angioplasty of the right coronary artery bifurcational stenosis. Cathet Cardiovasc Diagn 1988;14:37-40.
63. Thomas ES, Williams DO. Simultaneous double balloon coronary angioplasty through a single guiding catheter for bifurcation lesions. Cathet Cardiovasc Diagn 1988;15:260-4.
64. Myler RK, McConanhay DR, Stertzer SH, et al. Coronary bifurcation lesions: the kissing balloon probe technique via a single guiding catheter. Cathet Cardiovasc Diagn 1989;16:267-78.
65. Slack JD, Pinkerton CA. Complex coronary angioplasty: Use of extended and angled balloon catheters. Cathet Cardiovasc Diagn 1987;13:284-7.
66. Vivekaphirat V, Zapala C, Foschi AE. Clinical experience with the use of the angled-balloon dilatation catheter. Cathet Cardiovasc Diagn 1989;17: 121-5.
67. Kaltenbach M. The long-wire technique: a new technique for steerable balloon catheter dilatation of coronary artery stenoses. Eur Heart J 1984;5:1004-9.
68. Bonzel T, Wollschlager H, Just H. Ein neues Kathetersystem zur mechanischen Dilatation von Koronarstenosen mit austauschbaren intrakoronaren Kathetern, hoherem Kontrastmittelfluss und verbesserter Steuerbarkeit. Biomed Techn 1986;31:195-200.
69. Bonzel TR, Wollschlager H, Meinertz T, Kaspar W, Just H. The sliding rail (Monorail) principle: description of a new technique and its application for coronary angioplasty. In: Vogel JHK, King SB III, editors. Interventional Cardiology: Future Directions. St. Louis (MO): CV Mosby, 1989:320-326.
70. Finci L, Meier B, Roy P, Steffenino G, Rutishauser W. Clinical experience with the Monorail balloon catheter for coronary angioplasty. Cathet Cardiovasc Diagn 1988;14:206-12.
71. Hasdai D, Bell MR, Grill DE, et al. Outcome ≥10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1997;79: 1005-11.
72. Talley JD, Hurst JW, King SB III, et al. Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patients. Circulation 1988;77:820-9.
73. Mullin SM, Passamani ER, Mock MB. Historical background of the National Heart, Lung and Blood Institute Registry for Percutaneous Transluminal Coronary Angioplasty. Am J Cardiol 1984;53:3C-6C.
74. Mock MB, Bentivoglio L, Dorros G, et al. NHLBI Interim Registry for PTCA. Washington (DC): US Department of Health, Education, and Welfare: Publication No. (NIH):80:2030.
75. Kent KM, Bentivoglio L, Block PC, et al. Percutaneous transluminal coronary angioplasty: Report from the NHLBI Registry. Am J Cardiol 1982;49:2011-7.
76. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1988;12:529-45.
77. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB III, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985;72:1044-52.
78. Ellis SG, Roubin GS, King SB III, et al. In-hospital cardiac mortality following acute closure after percutaneous transluminal coronary angioplasty: analysis of risk factors from 8,207 procedures. J Am Coll Cardiol 1988;11:211-6.
79. Ellis SG, Myler RK, King SB III, et al. Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settings. Am J Cardiol 1991;68: 1447-51.
80. Whitworth HB, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
81. Leimgruber PP, Robin GS, Anderson HV, et al. Influence of intimai dissection on restenosis after successful angioplasty. Circulation 1985;72: 530-5.
82. Murphy DA, Craver JM, King SB. Distal coronary artery dissection following percutaneous transluminal coronary angioplasty. Ann Thorac Surg 1984;37:473-8.
83. Thornton MA, Gruentzig AR, Hollman J, King SB, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 1984;69:721-7.
84. Meier B, King SB, Gruentzig AR, et al. Repeat coronary angioplasty. J Am Coll Cardiol 1984;4:463-6.
85. Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984;53:77C-81C.
86. Leimgruber PP, Roubin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73/74:710-7.
87. Kaltenbach M, Kober G, Scherer D, Vallbracht C. Recurrence rate after successful coronary angioplasty. Eur Heart J 1985;6:276-81.
88. Meyer J, Schmitz H, Kiesslich T, et al. Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results. Am Heart J 1983;106:973-80.
89. Steffenino G, Meier B, Finci L, Rutishauser W. Followup results of treatment of unstable angina by coronary angioplasty. Br Heart J 1987;57: 416-9.
90. Gruentzig A. Results from coronary angioplasty and implications for the future. Am Heart J 1982;103:779-82.
91. Mabin T, Holmes DR Jr, Smith H, et al. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 1985;71:754-60.
92. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimai hyperplasia. Circulation 1989;79:1374-87.
93. Gravanis MB, Roubin GS. Histopathologic phenomena at the site of coronary angioplasty. Human Pathol 1989;20:477-85.
94. Waller BF. Morphologic correlates of coronary angiographic patterns at the site of coronary angioplasty. Clin Cardiol 1988;11:817-22.
95. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: Histopathologic study. J Am Coll Cardiol 1990;15:419-25.
96. Waller BF, McManus BM, Gorfinkel J, et al. Status of major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty: analysis of 3 necropsy patients. Am J Cardiol 1983;51:81-4.
97. Waller BF, Pinkerton CA, Orr CM, Slack JD, VanTasssel JW. Two distinct types of restenosis lesions after coronary balloon angioplasty: intimai proliferation and atherosclerotic plaques only: An analysis of 20 necropsy patients [abstract]. Circulation 1990;82 Suppl 111:111-314.
98. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-75.
99. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-200.
100. Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderberg K, King SB III. Coronary intimai proliferation after balloon injury and stenting in swine: An animal model of restenosis. J Am Coll Cardiol 1992;20:467-74.
101. Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 1987;60:21B-8B.
102. Adams PC, Badimon JJ, Badimon L, Chesebro JH, Fuster V. Role of platelets in atherogenesis: Relevance to coronary arterial restenosis after angioplasty. Cardiovasc Clin 1987;18:49-71.
103. Kohchi K, Takebayashi S, Block PC, Hiroki T, Nobuyoshi M. Arterial changes after percutaneous coronary angioplasty: results at autopsy. J Am Coll Cardiol 1987;10:592-9.
104. Ueda M, Becker AE, Fujimoto T. Pathological changes induced by repeated percutaneous transluminal coronary angioplasty. Br Heart J 1987;58:635-43.
105. Block PC, Myler RK, Stertzer S, Fallen JT. Morphology after PTCA in human beings. N Engl J Med 1981;305:382-5.
106. Färb A, Virmani R, Atkinson JB, Kolodgie FD. Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty. J Am Coll Cardiol 1990;16:1421-9.
107. Bertrand ME, LaBlanche JM, Fourrier JL, Traisnel G. Percutaneous transluminal coronary angioplasty in patients with spasm superimposed on atherosclerotic narrowing. Br Heart J 1987;58:469-72.
108. Bertrand ME, LaBlanche JM, Thieuleux FA, Fourrier JL, Traisnel G, Asseman P. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. J Am Coll Cardiol 1986;8:504-8.
109. Leisch F, Schutzenberger W, Kerschner K, Herbinger W. Influence of variant angina on the results of percutaneous transluminal coronary angioplasty. Br Heart J 1986;56:341-5.
110. Ardissino D, Barberis P, de Servi S, et al. Abnormal coronary vasoconstriction as a predictor of restenosis after successful angioplasty in patients with unstable angina pectoris. N Engl J Med 1991;325:1053-7.
111. Whitworth HB, Pilcher GS, Roubin GS, et al. Do proximal lesions involving the origin of the left anterior descending artery (IAD) have a higher restenosis rate after coronary angioplasty (PTCA) [abstract]? Circulation 1985;72:398.
112. Piovaccari G, Fattori R, Marzocchi Z, Marrozzini C, Prati F, Magnani B. Percutaneous transluminal coronary angioplasty of the very proximal left anterior descending artery lesions: immediate results and follow-up. Int J Cardiol 1991;30:151-5.
113. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Cox WR. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1989;63: 30-4.
114. Austin GE, Hollman J, Lynn MJ, Meier B. Serum lipoprotein levels fail to predict postangioplasty recurrent coronary artery stenosis. Cleve Clin J Med 1989;56:509-14.
115. Hearn JA, Donohue BC, King SB III, et al. Does serum LP(a) predict restenosis after PTCA [abstract]? J Am Coll Cardiol 1990;15 Suppl A:205A.
116. Plokker THW, Ernst SM, Bal ET, et al. Percutaneous transluminal coronary angioplasty in patients with unstable angina pectoris refractory to medical therapy: Long-term clinical and angiographic results. Cathet Cardiovasc Diagn 1988;14:15-8.
117. Johansson SR, Ekstrom L, Emanuelsson H. Higher recurrence rate after coronary angioplasty in unstable angina pectoris. Angiology 1991;42:273-80.
118. Luijten HE, Beatt KJ, de Feyter PJ, van den Brand M, Reiber JH, Serruys PW. Angioplasty for stable versus unstable angina pectoris: are unstable patients more likely to get restenosis? A quantitative angiographic study in 339 consecutive patients. Int J Card Imaging 1988;3:87-97.
119. Halon DA, Merdier A, Shefer A, Flugelman MY, Lewis BS. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. Am J Cardiol 1989;64:289-93.
120. Williams DO, Gruentzig AR, Kent KM, Detre KM, Kelsey SF, To T. Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis. Am J Cardiol 1984;53:32C-5C.
121. Black AJ, Anderson HV, Roubin GS, Powelson SW, Douglas JS Jr, King SB III. Repeat coronary angioplasty: Correlates of a second restenosis J Am Coll Cardiol 1988;11:714-8.
122. Deligonul U, Vandormael M, Kern MJ, Galan K. Repeat coronary angioplasty for restenosis: Results and predictors of follow-up clinical events. Am Heart J 1989;117:997-1002.
123. Steffenino G, Meier B, Finci L, Rutishauser W. Recurrence of stenosis after first and repeat coronary angioplasty: clinical and angiographic followup. G Ital Cardiol 1987;17:473-8.
124. Vandormael MG, Deligonul U, Kern MJ, Kennedy H, Galan K, Chaitman B. Restenosis after multilesion percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;60:44B-7B.
125. Lambert M, Bonan R, Cote G, et al. Early results, complications and restenosis rates after multilesion and multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;60:788-91.
126. Hirshfeld JW Jr, Schwartz JS, Jugo R, et al. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991;18:647-56.
127. Gibson CM, Kuntz RE, Nobuyoshi M, Rosnser B, Bairn DS. Lesion-tolesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy: Validation of lesion-based restenosis analysis. Circulation 1993;87:1123-9.
128. Hermans WR, Rensing BJ, Kelder JC, de Feyter PJ, Serruys PW. Postangioplasty restenosis rate between segments of the major coronary arteries. Am J Cardiol 1992;69:194-200.
129. Anderson HV, Roubin GS, Leimgruber PP, et al. Transstenotic pressure gradient measurements during percutaneous transluminal coronary angioplasty. Circulation 1986;73:1223-30.
130. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographie followup of 229 patients. J Am Coll Cardiol 1988;12:616-23.
131. Meier B, Gruentzig AR, King SB, et al. Higher balloon dilatation pressure in coronary angioplasty. Am Heart J 1984;10:619-22.
132. Roubin GS, Douglas JS Jr, King SB III, et al. Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty: A prospective randomized study. Circulation 1988;78:557-65.
133. Sarembock IJ, La Veau PJ, Sigal SL, et al. The influence of inflation pressure and balloon size on the development of intimai hyperplasia following balloon angioplasty: A study in the atherosclerotic rabbit. Circulation 1989;80:1029-40.
134. Quigley PJ, Perez J, Mikat E, et al. Effective prolonged balloon inflation on arterial hyperplasia in rabbits. Circulation 1986;4:184.
135. Ellis SG, Roubin GS, Wilentz J, et al. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777-82.
136. Urban P, Bulen N, Fox K, et al. Lack of effect of warfarin on the resenosis rate or on clinical outcome after balloon angioplasty. Br Heart J 1988;6: 485-8.
137. Wilentz JR, Sanborn TA, Hauderschild CC, et al. Platelet accumulation in experimental angioplasty. Circulation 1987;75:636-42.
138. Barnathan ES, Schwartz JS, Taylor L, et al. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angio-plasty. Circulation 1987;76:125-34.
139. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.
140. Dehmer GJ, Popma JJ, Van den Berg EK, et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988;319:733-40.
141. Reis GJ, Sipperly ME, Boucher TM, et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989;2:177-81.
142. Grigg LE, Kay TWH, Valentine PA, et al. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaneoic acid on incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 1988;12:1073-8.
143. Milner MR, Gallino RA, Leffingwell A, et al. Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal angioplasty. Am J Cardiol 1989;64:294-9.
144. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992;85:950-6.
145. Nye ER, Ilsley CDJ, Ablett MB, et al. Effect of eicosapentaneoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust NZ J Med 1990;20:549-52.
146. Pepine CJ, Hirshfeld JW, MacDonald RG, et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990;81:1753-61.
147. Stone GW, Rutherford BD, McConahay DR, et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 1989;18:227-31.
148. sis of simian sarcoma virus. Nature 1982;304:35-9.
149. Russell SB, Trupin KM, Rodriguez-Eaton S, et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 1988;85:587-91.
150. Rab ST, King SB III, Roubin GS, Carlin S, Hearn JA, Douglas JS Jr. Coronary aneurysms following stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 1991;18:1524-8.
151. Powell JS, Clozel JP, Muller RKS, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
152. The MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-10.
153. Faxon DP, on behalf of the Multicenter American Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;2:362-9.
154. Moreau JP, DeFeudis FU. Pharmacologic studies of somatostatin and somatostatin-analogues: Therapeutic advances and perspectives. Life Sci 1987;40:419-37.
155. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-7.
156. Yui Y, Kawai C, Hosoda S. Pravastatin (mevalotin) restenosis trial after percutaneous transluminal coronary angioplasty: Cholesterol reduction rate determines the restenosis rate. Ann N Y Acad Sei 1995;748:208-16.
157. Foley DP, Serruys PW. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological back-ground of the Fluvastatin Angioplasty Restenosis Trial. Br J Clin Pract Symp Suppl 1996;77A:40-53.
158. Liu MW, Roubin GS, Robinson KA, et al. Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 1990;81: 1089-93.
159. Maresta A, Balducelli M, Cantini L, Casari A, et al, for the STARC Investigators. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty: Results of the randomized double-blind STARC study. Circulation 1994;90:2710-5.
160. Schneider JE, Berk BC, Gravanis MB, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation 1993;88:628-37.
161. Lee YJ, Daida H, Yokoi H, et al. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty. Jpn Heart J 1996;37:327-32.
162. Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group. N Engl J Med 1997;337:365-72.
163. Wolinsky H, Thung SW. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 1991;15:475-81.
164. Santoian EC, Gravanis MB, Schneider JE, et al. Use of the porous balloon in porcine coronary arteries: rationale for low pressure and volume delivery. Cathet Cardiovasc Diagn 1993;30:348-54.
165. Slepian MJ. Polymeric endoluminal paving and sealing: therapeutics at the crossroad of biomechanics and pharmacology. In: Topol EJ, editor. Textbook of Interventional Cardiology. Philadelphia: WB Saunders, 1990:647-70.
166. Nabel EG, Plalutz G, Nabel GJ. Gene transfer into vascular cells. J Am Coll Cardiol 1991;17 Suppl B:189B-94B.
167. Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997;96:727-32.
168. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
169. Hartzler GO. Percutaneous transluminal coronary angioplasty in multivessel disease. Cathet Cardiovasc Diagn 1983;9:537-41.
170. Vlietstra RE, Holmes DR Jr, Reeder GS, et al. Balloon angioplasty in multivessel coronary artery disease. Mayo Clin Proc 1983;58:563-7.
171. Dorros G, Stertzer SH, Cowley MJ, Myler RK. Complex coronary angioplasty: multiple coronary dilatations. Am J Cardiol 1984;53:126C-30C.
172. Vandormael MG, Chaitman BR, Ischinger T, et al. Immediate and short-term benefit of multilesion coronary angioplasty: influence of degree of revascularization. J Am Coll Cardiol 1985;6:983-91.
173. Cowley MJ, Vetrovec GW, DiSciascio G, Lewis SA, Hirsh PD, Wolfgang TC. Coronary angioplasty of multiple vessels: short-term outcome and long-term results. Circulation 1985;72:1314-20.
174. Hartzler GO. Percutaneous coronary angioplasty in patients with multivessel disease. In: Jang GC, editor. Angioplasty. New York: McGraw-Hill, 1986:321-36.
175. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987;13:1-15.
176. Finci L, Meier B, de Bruyne B, Steffenino G, Divernois J, Rutishauser W. Angiographic follow-up after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;60:467-70.
177. Deligonul U, Vandormael MG, Kern MJ, Zelman R, Glan K, Chaitman BR. Coronary angioplasty: a therapeutic option for symptomatic patients with two or three vessel coronary disease. J Am Coll Cardiol 1988;11: 1173-9.
178. Dorros G, Lewis RF, Mathiak LM. Percutaneous transluminal coronary angioplasty in multivessel coronary disease patients: Short- and long-term follow-up in single and multiple dilatations. Clin Cardiol 1988;11:601-12.
179. Ellis SG, Fisher L, Dushman-Ellis S, et al. Comparison of coronary angioplasty with medical treatment for single- and double-vessel coronary disease with left anterior descending coronary involvement: Long term outcome based on an Emory-CASS Registry Study. Am Heart J 1989;118: 208-20.
180. Detre K, Holubkov R, Kelsey S, et al, and the Co-investigators of the NHLBIPTCA Registry. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981: the NHLBI Registry. N Engl J Med 1988;318: 265-70.
181. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987;13:1-15.
182. Holmes DR, Holubkov R, Vlietstra RE, et al, and Co-investigators of the
183. Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Ligon RW, Calkins MM. 'Long-term' clinical results of multiple lesion coronary angioplasty in 500 consecutive patients [abstract]. Circulation 1985;72 Suppl III:III-139.
184. Cowley MJ, Block PC. A review of the NHLBIPTCA Registry data. In Jang GC, editor. Angioplasty. New York: McGraw-Hill, 1986:368-77.
185. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987;13:1-15.
186. Roubin GS, Sutor C, Lembo NJ, et al. Prognosis after multiple vessel angioplasty (PTCA) in patients with coronary artery disease [abstract]. Circulation 1987;76 Suppl IV:IV-465.
187. Cowley MG, DiSciascio G, Kelly K, et al. Long-term efficacy of multiple-vessel coronary angioplasty [abstract]. Circulation 1987;76 Suppl IV:IV-466.
188. Dorros G, Lewin RF, Mathiak LM. Percutaneous transluminal coronary angioplasty in multivessel coronary disease patients: Short- and long-term follow-up in single and multiple dilatations. Clin Cardiol 1988;11:601-12.
189. Detre K, Holubkov R, Kelsey S, et al: Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. N Engl J Med 1988;318:265-70.
190. Detre K, Yeh W, Kelsey S, et al. Has improvement in PTCA intervention affected long-term prognosis? The NHLBI PTCA Registry experience. Circulation 1995;91:2868-75.
191. O'Keefe JH Jr, Rutherford BD, McConahay DR, et al. Multivessel coronary angioplasty from 1980-1989: procedural results and long-term outcome. J Am Coll Cardiol 1990;16:1079-102.
192. Holmes DR, Berger PB. Complex and multivessel dilatation. In: Topol EJ, editor. Textbook of Interventional Cardiology. Philadelphia: WB Saunders, 1994:231-50.
193. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation 1994;89:2015-25.
194. Hartz AJ, Kuhn EM, Fryer DB, et al. Mortality after coronary angioplasty and coronary artery bypass surgery (the National Medicare Experience). Am J Cardiol 1992;70:179-85.
195. Weintraub WS, Jones EL, King SB III, et al. Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease. Am J Cardiol 1990;65:183-8.
196. O'Keefe JH, Allan JJ, McCallister BD, et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction ≤40 percent. Am J Cardiol 1993;71:897-901.
197. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987;13:1-15.
198. Tyras DH, Barner HB, Kaiser GC, et al. Long-term results of myocardial revascularization. Am J Cardiol 1979;44:1290-6.
199. Cukingnan RA, Carey JS, Wittig JH, Brown BG. Influence of complete coronary revascularization on relief of angina. J Thorac Cardiovasc Surg 1980;79:188-93.
200. Jones EL, Craver JM, Guyton RA, Bone DK, Hatcher CR Jr, Riechwawld N. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983;51:7-12.
201. Vandormael M, Deligonul U. Multivessel coronary angioplasty. In: Meier B, editor. Interventional Cardiology. Toronto: Hogrefe and Huber, 1989: 117-43.
202. Mabin TA, Holmes DR, Smith HC, et al. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 1985;71:754-60.
203. Vandormael MG, Chaitman BR, Ischinger T, et al. Immediate and short-term benefit of multilesion coronary angioplasty: Influence of degree of revascularization. J Am Coll Cardiol 1985;6:983-91.
204. Bourassa MG, David PR, Costigan T, et al. Completeness of revascularization early after coronary angioplasty (PTCA) in the NHLBI PTCA Registry [abstract]. J Am Coll Cardiol 1987;Suppl A 9:19A.
205. Reeder GS, Holmes DR, Detre K, Costigan T, Kelsey SF. Degree of revascularization in patients with multivessel coronary disease: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1988;77:638-44.
206. Thomas ES, Most AS, Williams DO. Coronary angioplasty for patients with multivessel coronary artery disease: follow-up clinical status. Am Heart J 1988;115:8-13.
207. Holmes DR, Vlietstra RE, Hammes LN, Reeder GS, Mock MB. Does the disadvantage of incomplete revascularization by coronary angioplasty in-crease with time? [abstract]. J Am Coll Cardiol 1989;13 Suppl:229A.
208. Ischinger T, Gruentzig AR, Hollman J, et al. Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? Circulation 1983;68:148-54.
209. Breisblatt WM, Barnes JV, Weiland F, Spaccavento LJ. Incomplete revascularization in multivessel percutaneous transluminal coronary angioplasty: the role for stress thallium-201 imaging. J Am Coll Cardiol 1988;11:1183-90.
210. Bell MR, Bailey KR, Reeder GS, Lapeyre AC III, Holmes DR Jr. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival? J Am Coll Cardiol 1990;16:554-62.
211. Reeder TS, Holmes DR, Detre K, Costigan T, Kelsey SF. Degree of revascularization in patients with multivessel coronary disease: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1988;77:638-44.
212. Weintraub WS, King SB III, Jones EL, et al. Coronary surgery and coronary angioplasty in patients with two vessel coronary artery disease. Am J Cardiol 1993;71:511-7.
213. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-50.
214. Zhao X-Q, Brown BG, Stewart DK, et al. Effectiveness of revascularization in the Emory Angioplasty versus Surgery Trial: a randomized comparison of coronary angioplasty with bypass surgery. Circulation 1996;93:1954-62.
215. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease: Initial results from the era of coronary angioplasty. Circulation 1994;89:2015-25.
216. Holmes DR Jr, Vlietstra RE. Balloon angioplasty in acute and chronic coronary artery disease. JAMA 1989;261:2109-15.
217. Weintraub WS, Jones EL, King SB III, et al. Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease. Am J Cardiol 1990;65:183-8.
218. O'Keefe JH, Allan JJ, McCallister BD, et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction ≤40 percent. Am J Cardiol 1993;71:897-901.
219. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;3435:1184-9.
220. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH. Emory Angioplasty vs. Surgery Trial (EAST): design, recruitment and baseline description of patients. Am J Cardiol 1995;75:42C-59C.
221. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
222. CABRI Trial Participants. Coronary Angioplasty vs. Bypass Revascularization Investigation (CABRI) results during the first year. Lancet 1995;346: 1179-83.
223. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: The Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
224. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary artery disease. N Engl J Med 1994;331:1037-43.
225. Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol 1993;33:1060-7.
226. King SB III, Barnhart HX, Kosinski AS, et al. and the EAST Investigators. Angioplasty or surgery for multivessel coronary artery disease: Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Am J Cardiol 1997;79:1453-9.
227. Veterans Affairs ACME Investigators. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs cooperative randomized trial. J Am Coll Cardiol 1997;7: 1505-11.
228. RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: The second Randomised Interventional Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-8.
229. Boden WE, Dai H, on behalf of the VANQWISH Trial Investigators. Long-term outcomes in non-Q-wave infarction patients randomized to an "invasive" versus "conservative" strategy: results of the multicentre VA Non-Q-Wave Infarction Strategies In-hospital (VANQWISH) trial [abstract]. Eur Heart J 1997;18 Suppl:351.
230. King SB III. Trying to understand BARI. J Am Coll Cardiol 1997;30: 1426-7.
231. Meyer J, Merx W, Schmitz H, et al. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transluminal myocardial infarction. Circulation 1982;66:905-13.
232. Hartzler GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983;106:965-73.
233. TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI IIA results. JAMA 1988;260:2849-58.
234. Simoons ML, Arnold AER, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;1:197-203.
235. Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-8.
236. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.
237. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with antistreplase in acute myocardial infarction. BMJ 1991;302:555-60.
238. ISAM Study Group. A prospective trial of Intravenous Streptokinase in Acute Myocardial Infarction (ISAM): mortality, morbidity and infarct size at 21 days. N Engl J Med 1986;314:1465-71.
239. Gruppo Italiano per lo Studio della Streptochinasi nell'Inarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
240. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
241. Califf RM, Topol EJ, Stack RS, et al. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: results of Thrombolysis and Angioplasty in Myocardial Infarction-phase 5 randomized trial. Circulation 1991;83:1543-56.
242. Thrombolysis in Myocardial Infarction Investigators. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995;76:1108-11.
243. Ellis SG, da Silva ER, Heyndrickx G, et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure thrombolysis for acute anterior myocardial infarction. Circulation 1994;90:2280-4.
244. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
245. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ, for the Mayo Coronary Care Unit and Catheterization Laboratory Groups. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91.
246. Zijlstra F, de Boer MJ, Hoomtje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328: 680-4.
247. Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction: the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO lib). N Engl J Med 1997;336:1621-8.
248. Laster SB, Rutherford BD, McConahay DR, et al. Directional atherectomy of the left main coronary artery: acute and long term results [abstract]. J Am Coll Cardiol 1994;25 Suppl A:386A.
249. Lewis BE, Leya FS, Johnson SA, Grassman ED, McKleman TL, Hwang M. Outcomes of angioplasty (PTCA) and atherectomy (DCA) for bifurcation and nonbifurcation lesions in CAVEAT [abstract]. Circulation 1993;88 Suppl 1:1-601.
250. Leya FS, Lewis BE, Sumida CW, et al. Modified "kissing" atherectomy procedure with dependable protection of side branches by two-wire technique. Cathet Cardiovasc Diagn 1992;27:155-61.
251. Tuzcu EM, Berkalp B, DeFranco AC, et al. The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol 1996;27:832-8.
252. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional coronary atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-7.
253. Holmes DR Jr, Topol EJ, Califf RM, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation. In press.
254. Adelman AG, Cohen EA, Kimball BP, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993;329:228-33.
255. Elliott JM, Berdan LG, Holmes DR, One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I). Circulation 1995;91:2158-66.
256. Baim DS, Kuntz RE, Sharma SK, et al. Acute results of the randomized trial of the Balloon versus Optimal Atherectomy Trial (BOAT). Circulation 1995;91:1966-74.
257. Boehrer JD, Ellis SG, Keeler GP, et al. Differential benefit of directional atherectomy over angioplasty for left anterior descending in proximal, non ostial lesions: Results from CAVEAT [abstract]. J Am Coll Cardiol 1994;25 Suppl A:386A.
258. Popma JJ, Baim DS, Kuntz RE, et al. Early and late quantitative angiographic outcome from Optimal Atherectomy Restenosis Study (OARS) [abstract]. J Am Coll Cardiol 1996;27 Suppl A:291A.
259. Holmes DR Jr, Topol EJ, Califf RM, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions: CAVEAT-II Investigators. Circulation 1995;91:1966-74.
260. Popma JJ, Leon MB, Mintz GS, et al. Results of coronary angioplasty using the transluminal extraction catheter. Am J Cardiol 1992;70:1526-32.
261. Baim DS, Kent KM, King SB III, et al. Evaluating new devices: acute (in hospital) results from the New Approaches to Coronary Intervention Registry. Circulation 1994;89:471-81.
262. Moses JW, Teirstein PS, Sketch MH Jr, et al. Angiographic determinants of risk and outcome of coronary embolus and myocardial infarction (MI) with the transluminal extraction catheter (TEC): a report from the New Approaches to Coronary Intervention (NACI) Registry, [abstract] J Am Coll Cardiol 1994;25 Suppl A:220A.
263. Safian RD, Grines CL, May MA, et al. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994;89:302-12.
264. Safian RD, May MA, Lichtenberg A, et al. Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. J Am Coll Cardiol 1995;25:848-54.
265. Kaplan BM, Larkin T, Safian RD, et al. Prospective study of extraction atherectomy in patients with acute myocardial infarction. Am J Cardiol 1996;78:383-8.
266. Ritchie J, Hansen D, Vracko R, Auth D. Mechanical thrombolysis: a new rotational catheter approach for acute thrombi. Circulation 1986;73:1006-12.
267. Hansen D, Auth D, Vracko R, Ritchie J. Mechanical thrombectomy: a comparison of two rotational devices and balloon angioplasty in subacute canine femoral thrombosis. Am Heart J 1987;114:1223-31.
268. Fourrier J, Bertrand M, Auth D, Lablanche J, Gommeaux A, Brunetaud J. Percutaneous coronary rotational angioplasty in humans: preliminary report. J Am Coll Cardiol 1989;14:1278-82.
269. Reifart N, Vandormael M, Krajcar M, et al. Randomized comparison of angioplasty of complex coronary lesions at a single center: Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) study. Circulation 1997;96:91-8.
270. Teirstein PS, Warth DC, Haq N, et al. High speed rotational coronary atherectomy for patients with diffuse coronary artery disease. J Am Coll Cardiol 1991;18:1694-701.
271. Ellis SG, Popma JJ, Buchbinder M, et al. Relation of clinical presentation, stenosis morphology and operator technique to the procedural results of rotational atherectomy and rotational atherectomy facilitated angioplasty. Circulation 1994;89:882-92.
272. Litvack F, Grundfest W, Goldenberg T, Laudenslager J, Forrester J. Percutaneous excimer laser angioplasty of aortocoronary saphenous vein grafts. J Am Coll Cardiol 1989;14:803-8.
273. Litvack F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty. Am J Cardiol 1990;66:1027-32.
274. Murphy-Chutorian D, Kosek J, Mok W, et al. Selective absorption of ultraviolet laser energy by human atherosclerotic plaque treated with tetracycline. Am J Cardiol 1985;55:1293-7.
275. Vandormael M, Reifart N, Preusler W, et al. In hospital costs comparison of excimer laser angioplasty, rotational atherectomy (Rotablator) and balloon angioplasty for complex coronary lesions: A randomized trial (ERBAC) [abstract]. J Am Coll Cardiol 1994;25 Suppl A:753A-4A.
276. Douglas JS Jr, Ghazzal ZMG, Ba'albaki HA, Miller SJ, King SB III. Excimer laser coronary angioplasty of ostial lesions: Acute success and complications [abstract]. Cathet Cardiovasc Diagn 1991;23:75.
277. Eigler NL, Douglas JS Jr, Margolis JR, Hestrin L, Litvack FL, ELCA Investigators: Excimer laser coronary angioplasty of aorto-ostial stenosis: results of the ELCA Registry. Circulation 1993;88:2049-57.
278. Bittl JA, Sanborn TA, Yardley DE, et al. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol 1994;74:144-8.
279. de Marchene EJ, Mallon SM, Knopf WD, et al. Effectiveness of homium laser-assisted coronary angioplasty. Am J Cardiol 1994;73:117-21.
280. Litvack F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty: Results in the first consecutive 3,000 patients. J Am Coll Cardiol 1994;23:323-9.
281. Ghazzal Z, Hearn J, Litvack F, et al. Morphologic predictors of acute complications after percutaneous excimer laser coronary angioplasty: results of a comprehensive angiographic analysis: Importance of the eccentricity index. Circulation 1992;86:820-7.
282. Karsch K, Haase K, Voelker W, Baumbach A, Mauser M, Seipel L. Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris: acute results and incidence of restenosis during 6-month follow-up. Circulation 1990;81:1849-59.
283. Appelman YE, Piek JJ, deFeyter PJ, Koolen JJ, Strikwerda S, Margolis JR. Excimer laser coronary angioplasty versus balloon angioplasty used in long-term lesions: The long-term results of the AMRO Trial [abstract]. J Am Coll Cardiol 1995;25 Suppl A:329A.
284. Appelman JY, Koolen JJ, deFeyter PJ, Strikwerda S, David GK, Redekop K. Long-term outcome of excimer laser angioplasty versus balloon angioplasty in functional and total coronary occlusions [abstract]. J Am Coll Cardiol 1995;25 Suppl A:330A.
285. Vandormael M, Riefart N, Preusler W. Six month follow-up results following excimer laser angioplasty, rotational atherectomy and balloon angioplasty for complex lesions: ERBAC Study [abstract]. Circulation 1994;90 Suppl 1:1-213.
286. Ghazzal ZM, Burton E, Weintraub WS, et al. Predictors of restenosis after excimer laser coronary angioplasty. Am J Cardiol 1995;75:1012-4.
287. Serruys PW, Hamburger J, Fleck E, Koolen JJ, Teunissen. Laser guide wire: A powerful tool in recanalization of chronic total coronary occlusion [abstract]. Circulation 1995;92 Suppl 1:1-76.
288. King SB III, Yeh W, Holubkov R, et al, for the Investigators of the NHLBI PTCA and NACI Registries. Balloon angioplasty versus new device intervention, clinical outcomes: a comparison of the NHLBIPTCA registry and the NACI registry. J Am Coll Cardiol. In press.
289. Roubin GS, King SB III, Douglas JS Jr, Lembo NJ, Robinson KA. Intracoronary stenting during percutaneous transluminal coronary angioplasty [abstract]. Circulation 1990;81 Suppl IV:IV-92-100.
290. Hearn JA, King SB III, Douglas JS Jr, Carlin SF, Lembo NJ, Ghazzal ZMB. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty: initial results with a balloon-expandable, stainless steel design. Circulation 1993;88:2086-96.
291. Dean LS, George CJ, Roubin GS, et al. Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: operator reports and angiographie core laboratory verification from the National Heart, Lung, and Blood Institute/New Approaches to Coronary Intervention Registry. J Am Coll Cardiol 1997;5:934-40.
292. Schatz R, Baim D, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation 1991;83:148-61.
293. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter US Palmaz-Schatz stent experience: The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995;26:704-12.
294. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
295. Serruys PW, de Jaegere P, Kiemeneij F, et al, on behalf of the BENESTENT Study Group: a comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
296. Barragan P, Sainsous J, Silvestri M, et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994;32:133-8.
297. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
298. Schoemig A Newmann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996;334:1084-9.
299. Schuhlen H, Hadamitzky M, Walter H, Ulm K, Schomig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation 1997;95:2015-21.
300. Leon MB, Cutlip DE, Fitzpatrick M, et al. Acute results and one-year outcomes of the Stent Anti-thrombotic Regimen Study (STARS) registry [abstract]. Circulation 1997;96 Suppl 1:1-594.
301. Savage MP, Douglas JS Jr, Fischman DL, et al, for the Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-7.
302. Mehran R, Mintz GS, Popma JJ, et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 1996;78: 618-22.
303. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimai hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-4.
304. Hong MK, Kent KM, Mehran R, et al. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation 1997;95:449-54.
305. Reimers B, Moussa I, Akiyama T, et al. Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coll Cardiol 1997;30:86-92.
306. King SB III, Williams DO, Chougule P, et al. Endovascular beta radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation. In press.
307. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB III. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiation therapy in restenosis prevention. Circulation 1995;91:1533-9.
308. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation 1995;92:1383-6.
309. Stone GW, Hodgson JM, Goar FG, et al. Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: the CLOUT pilot trial. Circulation 1997;95:2044-52.
310. McPherson DD, Kane BJ. Intravascular ultrasound: three-dimensional applications and forward viewing. Cardiol Clin 1997;15:63-75.
311. Gorge G, Ge J, Haude M, et al. Intravascular ultrasound for evaluation of coronary arteries. Herz 1996;21:78-89.
312. Bach RG, Donohue TJ, Kern MJ. Intracoronary Doppler flow velocity measurements for the evaluation and treatment of coronary artery disease. Curr Opin Cardiol 1995;10:434-42.
313. Kern MJ, Donohue TJ, Aguirre FV, et al. Assessment of angographically intermediate coronary artery stenosis using the Doppler FloWire. Am J Cardiol 1993;71:26D-33D.
314. Anderson HV, Roubin GS, Leimgruber PP, et al. Transtenotic pressure gradient measurements during percutaneous transluminal coronary angio-plasty. Circulation 1986;73:1223-30.
315. Redd D, Roubin GS, Leimgruber PP, Abi-Mansour P, Douglas JS, King SB. The transstenotic pressure gradient trend as a predictor of acute complications after percutaneous transluminal coronary angioplasty. Cir-culation 1987;76:792-801.
316. Pijls NHJ, Van Son JAM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA. Circulation 1993;87:1354-67.
317. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
318. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularizatiaon. N Engl J Med 1997;336:1689-96.
319. The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445-53.
320. Harrington RA. Design and methodology of the PURSUIT trial: evaluating entifibatide for acute ischemic coronary syndromes (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy trial). Am J Cardiol 1997;80:34B-38B.
321. Grines CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27:1381-6.
322. Ritchie JL, Nissen SE, Douglas JS Jr, et al. Use of nonionic or low osmolar contrast agents in cardiovascular procedures. J Am Coll Cardiol 1993;21: 269-73.
323. Lembo NJ, King SB III, Roubin GS, Black AJ, Douglas JS Jr. Effects of nonionic contrast media on complications of percutaneous transluminal coronary angioplasty. Am J Cardiol 1991;67:1046-50.
324. Poole JCF, Cromwell SB, Benditt EP. Behavior of smooth muscle cells and formation of extracellular structures in the reaction of arterial walls to injury. Am J Pathol 1971;62:391-404.
325. Jorgensen L, Roswell HC, Hovig T, Mustard JF. Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am J Pathol 1967;51:681-719.
326. Webster WS, Bishop SP, Geer JC. Experimental aortic intimai thickening: I: Morphology and source of intimai cells. Am J Pathol 1974;76:245-64.
327. Schlichter JG. Experimental medionecrosis of the aorta. Arch Pathol 1946;42:182-92.
328. Buck RC. Intimai thickening after ligature of arteries: an electron microscopic study. Circ Res 1961;9:418-26.
329. Stemerman MB, Spaet TH, Pitlick F, Cintron J, Lejnieks I, Tiell ML. Intimal healing: the pattern of reendothelialization and intimal thickening. Am J Pathol 1977;87:125-42.
330. Groves HM, Kinlough-Rathbone RL, Richardson M, Jorgensen L, Moore S, Mustard JF. Thrombin generation and fibrin formation following injury to rabbit neointima: Studies of vessel wall reactivity and platelet survival. Lab Invest 1982;46:605-12.
331. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury: I: smooth muscle cell growth in the absence of endothelium. Lab Invest 1983;49:327-43.
332. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-73.
333. Nikol S, Huehns TY, Hofling B. Molecular biology and post-angioplasty restenosis. Atherosclerosis 1996;123:17-31.
334. Wilcox JN. Molecular biology: Insight into the causes and prevention of restenosis after arterial intervention. Am J Cardiol 1993;72:88E-95E.
335. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: A special case of atherosclerosis progression [abstract]. Circu-lation 1992;86 Suppl III:III-47-52.
336. Lee PC, Gibbons GH, Dzau VJ. Cellular and molecular mechanisms of coronary artery restenosis. Coron Artery Dis 1993;4:254-9.
337. Badimon L, Alfon J, Royo T, Berrozpe M, et al. Cell biology of restenosis post-angioplasty. Z Cardiol 1995;84 Suppl 4:145-9.
338. Panda D, Kundu GC, Lee BI, et al. Potential roles of osteopontin and αVβ3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci USA 1997;94:9308-13.
339. van Bockxmeer FM, Mamotte CD, Gibbons FA, Burke V, Taylor RR. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation 1995;92:2066-71.
340. Johansson SR, Nilsson J, Hamsten A, Emanuelsson H. Mitogenic activity in connection with coronary angioplasty. Eur Heart J 1993;14:904-9.
341. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
342. O'Brien ER, Garvin MR, Stewart DK, et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and rest-enotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994; 14:1648-56.
343. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997;95:1998-2002.
344. Robinson KA, King SB III. Prospects for local delivery. In Ellis S, Holmes D, editors. Strategic Approaches in Coronary Intervention. Baltimore: Williams & Wilkins, 1996:698-710.
345. Edelman ER, Levy RJ, editors. Molecular Interventions and Local Drug Delivery, Frontiers in Cardiology Series. Cambridge (MA): Cambridge University Press, 1995.
346. Waksman R, King SB III, Crocker IR, Mould RF, editors. Vascular Brachytherapy. Veneendal, The Netherlands: Nucletron-Oldeft, 1996.
347. March K, editor. Gene Transfer in the Cardiovascular System: Experimental Approaches and Therapeutic Implications. Boston: Kluwer, 1997.
348. Nunes GL, Sgoutas DS, Redden RA, et al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vase Biol 1995;15:156-65.
349. Wu K, Robinson KA, Cui J, et al. Chronic treatment with a glutathione peroxidase mimic, BXT-51072, improves in vitro relaxation to ACh in pig coronary arteries with regenerated endothelium [abstract]. Circulation 1996;94 Suppl I:I-522.
350. 2 production in the pig coronary artery. Circulation 1997;96:3593-601.
351. Yokoi H, Daida H, Kuwbara Y, et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol 1997;30:855-62.
352. Ryan TJ, Bauman WB, Kennedy JW, et al. ACC/AHA Task Force Report: guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:2033-54.
353. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 1997;277: 892-8.
354. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation 1997;95:2485-91.
355. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SB III. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation 1997;96:2479-84.
356. Topol EJ, Califf RM, Van de Werf F, et al, for thé Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group. Perspectives on large-scale cardiovascular clinical trials for the new millennium. Circulation 1997;95:1072-82.